We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Cisbio Bioassays Marks Next Step in Development of Tag-lite™ GPCR Investigation Platform
News

Cisbio Bioassays Marks Next Step in Development of Tag-lite™ GPCR Investigation Platform

Cisbio Bioassays Marks Next Step in Development of Tag-lite™ GPCR Investigation Platform
News

Cisbio Bioassays Marks Next Step in Development of Tag-lite™ GPCR Investigation Platform

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Cisbio Bioassays Marks Next Step in Development of Tag-lite™ GPCR Investigation Platform"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Cisbio Bioassays, a member of IBA group and global developer of HTRF® (Homogeneous Time-Resolved Fluorescence) technology and services
used in assay development and drug screening, today announced that it has extended its Tag-lite™ cell surface receptor platform with the introduction of a comprehensive catalogue of ligands and plasmids.
The new catalogue marks the next step in the company’s development of a complete array of tools for G-Protein Coupled Receptor (GPCR) investigation and, more specifically, of Tag-lite, its homogeneous and non-radioactive
alternative for the study of cell surface receptor dimerization and ligand binding.
Advertisement